Literature DB >> 9668116

A splice variant of E2-2 basic helix-loop-helix protein represses the brain-specific fibroblast growth factor 1 promoter through the binding to an imperfect E-box.

Y Liu1, S K Ray, X Q Yang, V Luntz-Leybman, I M Chiu.   

Abstract

We previously demonstrated that a cis-element (-489 to -467) in the brain-specific fibroblast growth factor (FGF)-1 promoter (FGF-1.B) binds multiple nuclear factors, and this binding enhances transcriptional activity of this promoter. Here we report the isolation of three cDNA clones, VL1, VL2 and VL3, from a human brain stem cDNA expression library using four tandem repeats of the 26-base pair sequence (-492 to -467) as the probe. These cDNA clones represent the variant of bHLH protein E2-2/SEF2-1 in having 12 additional nucleotides encoding the amino acids RSRS. The glutathione S-transferase (GST) fusion proteins of VLl, VL2, and VL3 immunologically react with anti-E2-2 antibody and anti-GST-VL2 antibody. Electrophoretic mobility shift assay and methylation interference assay revealed that the GST fusion proteins specifically bind to an imperfect E-box sequence (GACCTG) present in the 26-base pair sequence. Transient expression of the full-length E2-2 without RSRS in U1240MG glioblastoma cells resulted in repression of FGF-1.B promoter activity. We further showed a significant repression of promoter activity (>40 fold) by E2-2 (lacking the amino acid sequence RSRS) when the E47 reporter construct, containing a hexameric E-box site, was used. In contrast, the E2-2 variant containing the RSRS sequence has no significant effect on either the FGF-1 promoter or E47 promoter. These results suggest that the relative abundance of the two splice variants of E2-2 in brain could be an important determinant for the expression of FGF-1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668116     DOI: 10.1074/jbc.273.30.19269

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Id1 modulates endothelial progenitor cells function through relieving the E2-2-mediated repression of FGFR1 and VEGFR2 in vitro.

Authors:  Yang Yu; Yuan Liang; Xiaoli Liu; Haijie Yang; Yong Su; Xi Xia; Hong Wang
Journal:  Mol Cell Biochem       Date:  2015-10-17       Impact factor: 3.396

2.  High expression of transcription factor 4 (TCF4) is an independent adverse prognostic factor in acute myeloid leukemia that could guide treatment decisions.

Authors:  Florentien E M in 't Hout; Bert A van der Reijden; Davide Monteferrario; Joop H Jansen; Gerwin Huls
Journal:  Haematologica       Date:  2014-08-22       Impact factor: 9.941

3.  Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome).

Authors:  Christiane Zweier; Maarit M Peippo; Juliane Hoyer; Sergio Sousa; Armand Bottani; Jill Clayton-Smith; William Reardon; Jorge Saraiva; Alexandra Cabral; Ina Gohring; Koen Devriendt; Thomy de Ravel; Emilia K Bijlsma; Raoul C M Hennekam; Alfredo Orrico; Monika Cohen; Alexander Dreweke; Andre Reis; Peter Nurnberg; Anita Rauch
Journal:  Am J Hum Genet       Date:  2007-03-23       Impact factor: 11.025

4.  SRY induced TCF21 genome-wide targets and cascade of bHLH factors during Sertoli cell differentiation and male sex determination in rats.

Authors:  Ramji K Bhandari; Ellyn N Schinke; Md M Haque; Ingrid Sadler-Riggleman; Michael K Skinner
Journal:  Biol Reprod       Date:  2012-12-06       Impact factor: 4.285

5.  Alternative splicing is frequent during early embryonic development in mouse.

Authors:  Timothée Revil; Daniel Gaffney; Christel Dias; Jacek Majewski; Loydie A Jerome-Majewska
Journal:  BMC Genomics       Date:  2010-06-23       Impact factor: 3.969

6.  Common variants at VRK2 and TCF4 conferring risk of schizophrenia.

Authors:  Stacy Steinberg; Simone de Jong; Ole A Andreassen; Thomas Werge; Anders D Børglum; Ole Mors; Preben B Mortensen; Omar Gustafsson; Javier Costas; Olli P H Pietiläinen; Ditte Demontis; Sergi Papiol; Johanna Huttenlocher; Manuel Mattheisen; René Breuer; Evangelos Vassos; Ina Giegling; Gillian Fraser; Nicholas Walker; Annamari Tuulio-Henriksson; Jaana Suvisaari; Jouko Lönnqvist; Tiina Paunio; Ingrid Agartz; Ingrid Melle; Srdjan Djurovic; Eric Strengman; Gesche Jürgens; Birte Glenthøj; Lars Terenius; David M Hougaard; Torben Ørntoft; Carsten Wiuf; Michael Didriksen; Mads V Hollegaard; Merete Nordentoft; Ruud van Winkel; Gunter Kenis; Lilia Abramova; Vasily Kaleda; Manuel Arrojo; Julio Sanjuán; Celso Arango; Swetlana Sperling; Moritz Rossner; Michele Ribolsi; Valentina Magni; Alberto Siracusano; Claus Christiansen; Lambertus A Kiemeney; Jan Veldink; Leonard van den Berg; Andres Ingason; Pierandrea Muglia; Robin Murray; Markus M Nöthen; Engilbert Sigurdsson; Hannes Petursson; Unnur Thorsteinsdottir; Augustine Kong; I Alex Rubino; Marc De Hert; János M Réthelyi; István Bitter; Erik G Jönsson; Vera Golimbet; Angel Carracedo; Hannelore Ehrenreich; Nick Craddock; Michael J Owen; Michael C O'Donovan; Mirella Ruggeri; Sarah Tosato; Leena Peltonen; Roel A Ophoff; David A Collier; David St Clair; Marcella Rietschel; Sven Cichon; Hreinn Stefansson; Dan Rujescu; Kari Stefansson
Journal:  Hum Mol Genet       Date:  2011-07-26       Impact factor: 6.150

7.  Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5' exon usage and splicing.

Authors:  Mari Sepp; Kaja Kannike; Ave Eesmaa; Mari Urb; Tõnis Timmusk
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

8.  Knockdown of human TCF4 affects multiple signaling pathways involved in cell survival, epithelial to mesenchymal transition and neuronal differentiation.

Authors:  Marc P Forrest; Adrian J Waite; Enca Martin-Rendon; Derek J Blake
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

9.  Characterization of sequences in human TWIST required for nuclear localization.

Authors:  Shalini Singh; Anthony O Gramolini
Journal:  BMC Cell Biol       Date:  2009-06-17       Impact factor: 4.241

10.  Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression.

Authors:  Anna Lagergren; Christina Manetopoulos; Håkan Axelson; Mikael Sigvardsson
Journal:  BMC Cancer       Date:  2004-11-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.